$20M VSL Pharmaceuticals Probiotic Class Action Settlement
Case Overview
VSL Pharmaceuticals has agreed to a $20 million class action settlement to address allegations that the company falsely advertised its VSL#3 probiotic as being clinically proven to treat specific medical conditions. This action pertains to consumers who purchased the VSL#3 product within the United States during the period spanning from June 1, 2016, to June 19, 2019.
The plaintiffs alleged that the false advertising by VSL Pharmaceuticals caused consumers to overpay for the probiotic. While the company has not admitted any wrongdoing, it reached this settlement to resolve the claims regarding the misleading advertising.
To receive benefits, class members must submit a valid claim form by the deadline of October 20, 2026. Those with proof of purchase can claim up to 40 units for a potential payment of up to $800, while those without proof of purchase can claim one unit for up to $20. The final approval hearing is set for January 6, 2027.
Who May Qualify
Consumers who purchased VSL#3 in the United States between June 1, 2016, and June 19, 2019.
Frequently Asked Questions
Who is eligible for this settlement?
The settlement benefits consumers who purchased VSL#3 in the United States between June 1, 2016, and June 19, 2019.
How much money can I potentially receive?
If you have proof of purchase, you can claim up to 40 units for a payment of up to $800. If you do not have proof of purchase, you can claim one unit for up to $20.
What is the deadline to file a claim?
Class members must submit a valid claim form by October 20, 2026.
Related Cases
AMC Allegedly Charges Hidden Fees for Online Movie Tickets
Edikted Allegedly Charging Junk Shipping Fees